Guided Therapeutics Inc.
Guided Therapeutics Inc. is listed today as Guided Therapeutics Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2015 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| Apr 2014 | $3 M | Private placement after listing | $2 to $10 million | debt, options | SEC | |
| May 2013 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| Aug 2010 | $3 M | No. 1 | $2 to $10 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Guided Therapeutics Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Jul 2015).
SEC Form D (revenue range) · Jul 2015
Revenue range over time, as stated in its notices: revenue of up to $1 million in 2010; revenue between $1 million and $5 million in 2013; revenue between $1 million and $5 million in 2014; revenue between $1 million and $5 million in 2015.
SEC Form D (revenue range) · Jul 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2015
Products and services#
No products or services of Guided Therapeutics Inc. are on record.
Investors#
3 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Alan Grujic | Person | not stated | not stated | Held Series E preferred stock, director (Form 3, 2023) | SEC Form 3 |
| John E. Imhoff | Person | not stated | not stated | Held Series A preferred stock, 10% owner, director (Form 3, 2011) | SEC Form 3 |
| Lynne H. Imhoff | Person | not stated | not stated | Held Series C-1 preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 3 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Gene S. Cartwright | Executive officer | Jul 2015 |
| Rick M. Fowler | VP Engineering | Jul 2015 |
| Mark L Faupel | Executive officer | Jun 2013 |
| Richard L Fowler | Executive officer | Jun 2013 |
| Richard L. Fowler | Executive officer | Sep 2010 |
| Shabbir L. Bambot | Executive officer | Sep 2010 |
| Gene S. Cartwright | Director | Jul 2015 |
| John E. Imhoff | Director | Jul 2015 |
| Johnathan M. Niloff | Director | Jul 2015 |
| Linda M. Rosenstock | Director | Jul 2015 |
| Michael C. James | Director | Jul 2015 |
| Ronald W. Hart | Director | Jul 2015 |
| Jonathan M. Niloff | Director | May 2014 |
| Mark L. Faupel | Director | May 2014 |
| John E Imhoff | Director | Jun 2013 |
| Jonothan M Niloff | Director | Jun 2013 |
| Linda M Rosenstock | Director | Jun 2013 |
| Mark L Faupel | Director | Jun 2013 |
| Michael C James | Director | Jun 2013 |
| Ronald W Allen | Director | Jun 2013 |
| Ronald W Hart | Director | Jun 2013 |
| Jonathan M Niloff | Director | Sep 2010 |
| William E Zachary | Director | Sep 2010 |
Went public since 2012. Its SEC number is that of a company listed on a stock exchange.